Citation: M. Okita et al., ELEVATED LEVELS AND ALTERED FATTY-ACID COMPOSITION OF PLASMA LYSOPHOSPHATIDYLCHOLINE (LYSOPC) IN OVARIAN-CANCER PATIENTS, International journal of cancer, 71(1), 1997, pp. 31-34
Citation: I. Mani et al., INCREASED FORMATION OF PHOSPHATIDYLINOSITOL-4-PHOSPHATE IN HUMAN PLATELETS STIMULATED WITH LYSOPHOSPHATIDIC ACID, Lipids, 31(12), 1996, pp. 1265-1268
Authors:
XU Y
GAUDETTE DC
BOYNTON JD
FRANKEL A
FANG XJ
SHARMA A
HURTEAU J
CASEY G
GOODBODY A
MELLORS A
HOLUB BJ
MILLS GB
Citation: Y. Xu et al., CHARACTERIZATION OF AN OVARIAN-CANCER ACTIVATING FACTOR IN ASCITES FROM OVARIAN-CANCER PATIENTS, Clinical cancer research, 1(10), 1995, pp. 1223-1232
Citation: M. Indu et al., INCREASED FORMATION OF PHOSPHOTIDYLINOSITOL-4-PHOSPHATE (PI-4-P) IN HUMAN PLATELETS STIMULATED WITH PALMITOYL LYSOPHOSPHATIDIC ACID, The FASEB journal, 9(3), 1995, pp. 116-116
Authors:
TURINI ME
GAUDETTE DC
HOLUB BJ
KIRKLAND JB
Citation: Me. Turini et al., CORRELATION BETWEEN PLATELET-AGGREGATION AND DEPHOSPHORYLATION OF A 68 KDA PROTEIN REVEALED THROUGH THE USE OF PUTATIVE PKC INHIBITORS, Thrombosis and haemostasis, 70(4), 1993, pp. 648-653
Authors:
GAUDETTE DC
AUKEMA HM
JOLLY CA
CHAPKIN RS
HOLUB BJ
Citation: Dc. Gaudette et al., MASS AND FATTY-ACID COMPOSITION OF THE 3-PHOSPHORYLATED PHOSPHATIDYLINOSITOL BISPHOSPHATE ISOMER IN STIMULATED HUMAN PLATELETS, The Journal of biological chemistry, 268(19), 1993, pp. 13773-13776